Zscaler’s SWOT analysis: stock navigates growth concerns and market leadership

Zscaler is targeting $10 billion in ARR and more than 20% long-term topline growth, with analysts forecasting EPS of $3.66-$3.80 in the first fiscal year and $4.22-$4.32 in the second. The company generated $3.0 billion in trailing revenue, ~77% gross margin, and nearly $947 million in levered free cash flow, but concerns over mid-teens organic growth and execution led to a price target cut to $305 from $350. Shares are down about 37% over six months, though the article argues the stock may still be undervalued.

Analysis

ZS is in a classic “good business, tougher stock” setup: fundamentals can remain intact while multiple compression continues if management cannot re-accelerate billings and net new ARR. The market is implicitly pricing in a durability discount on growth, and that creates asymmetry into the next catalyst window: if investor day merely confirms the current glide path, the stock can keep drifting lower, but any credible evidence that mid-teens organic growth is temporary should force a sharp repricing because the valuation already reflects skepticism.

The second-order winner here may be larger incumbent security platforms that can bundle adjacent products and win budget-share from customers looking to simplify vendor stacks. If ZS is forced to defend growth with more platform expansion and sales intensity, that can pressure margins near term and make the “fast growth plus expanding profitability” narrative harder to sustain. The Red Canary angle matters less as a direct revenue contributor and more as a signal that ZS may need acquisitions to fill product gaps, which is usually a late-cycle behavior when organic momentum slows.

The key risk is not an existential slowdown; it is a prolonged proof gap over the next 1-2 quarters. Seasonal softness can mask whether demand is truly decelerating, so the stock may remain range-bound until management supplies a cleaner bridge to the FY28 ARR target. If guidance on investor day is conservative but not decisive, expect the sell-side to cut models again and keep the multiple pinned.

Contrarian take: the consensus may be overemphasizing rate-of-change weakness and underweighting the compounding effect of a large installed base plus secular migration. For a company with high gross margin and strong FCF generation, a few points of growth re-acceleration can matter more to valuation than the market currently admits. The best entry is likely on any post-event disappointment that is narrative-driven rather than fundamental, because that is where upside skew is best.

Key Decisions for Investors

• Wait for investor day before adding risk; if management quantifies a credible path back to >20% topline growth, buy ZS on the first 3-5% post-event dip with a 3-6 month horizon and target a 15-20% rebound on multiple expansion.
• If the company reiterates mid-teens organic growth without better forward indicators, short ZS into strength or buy put spreads expiring 60-90 days out; the setup favors 1.5:1 to 2:1 downside/upside because the stock is still vulnerable to another guidance reset.
• Pair trade: long PANW or CRWD against short ZS for the next 1-2 quarters to express relative execution dispersion in cyber; ZS carries more downside if growth credibility remains in question, while peers with broader platform narratives should hold valuation better.
• For event-driven traders, sell out-of-the-money calls into any pre-investor-day rally; implied volatility likely overstates upside if the event is “clarity” rather than “acceleration,” making premium harvest attractive.
• If the stock sells off hard on an in-line update, accumulate a starter long only if ARR continues to beat modestly and FCF stays strong; that combination would signal the market is over-discounting a temporary slowdown, with 6-12 month upside if sentiment normalizes.